Cargando…

Second-line glucose-lowering drugs added to metformin and the risk of hospitalization for heart failure: A nationwide cohort study

AIM: To compare the risks of hospitalization for heart failure (HHF) associated with sulfonylurea (SU), dipeptidyl peptidase-4 inhibitor (DPP-4i), and thiazolidinedione (TZD) as add-on medications to metformin (MET) therapy using the data of Korean adults with type-2 diabetes from the Korean Nationa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Su Jin, Ha, Kyoung Hwa, Lee, Jung Hyun, Lee, Hokyou, Kim, Dae Jung, Kim, Hyeon Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370220/ https://www.ncbi.nlm.nih.gov/pubmed/30742667 http://dx.doi.org/10.1371/journal.pone.0211959

Ejemplares similares

Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study
por: Chung, Yoo-Ri, et al.
Publicado: (2019)

Cardiovascular Safety of Sodium Glucose Cotransporter 2 Inhibitors as Add-on to Metformin Monotherapy in Patients with Type 2 Diabetes Mellitus
por: Jeon, Ja Young, et al.
Publicado: (2021)

Response: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640–8)
por: Chung, Yoo-Ri, et al.
Publicado: (2019)

Effectiveness and safety of sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors in older adults with type 2 diabetes: A nationwide population‐based study
por: Han, Seung Jin, et al.
Publicado: (2020)

Temporal and Geospatial Trends of Hypertension Management in Korea: a Nationwide Study 2002–2016
por: Lee, Hokyou, et al.
Publicado: (2019)

Metabolic Dysfunction–Associated Fatty Liver Disease Increases Colon Cancer Risk: A Nationwide Cohort Study
por: Lee, Hokyou, et al.
Publicado: (2022)

Effects of sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on diabetic retinopathy and its progression: A real-world Korean study
por: Chung, Yoo-Ri, et al.
Publicado: (2019)

Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme
por: Khunti, Kamlesh, et al.
Publicado: (2020)

Coexisting and Second Primary Cancers in Patients with Uveal Melanoma: A 10-Year Nationwide Database Analysis
por: Kim, Yong Joon, et al.
Publicado: (2021)

Combined Effect of Income and Medication Adherence on Mortality in Newly Treated Hypertension: Nationwide Study of 16 Million Person‐Years
por: Lee, Hokyou, et al.
Publicado: (2019)

Antihypertensive Medication Adherence and Cardiovascular Outcomes in Patients With Cancer: A Nationwide Population‐Based Cohort Study
por: Jung, Mi‐Hyang, et al.
Publicado: (2023)

Association of Body Mass Index with Risk of Major Adverse Cardiovascular Events and Mortality in People with Diabetes
por: Lee, Dong Hun, et al.
Publicado: (2018)

Sex-Specific Trends in the Prevalence of Hypertension and the Number of People With Hypertension: Analysis of the Korea National Health and Nutrition Examination Survey (KNHANES) 1998–2018
por: Seo, Eunsun, et al.
Publicado: (2022)

Korea hypertension fact sheet 2020: analysis of nationwide population-based data
por: Kim, Hyeon Chang, et al.
Publicado: (2021)

Korea hypertension fact sheet 2021: analysis of nationwide population-based data with special focus on hypertension in women
por: Kim, Hyeon Chang, et al.
Publicado: (2022)

Korea hypertension fact sheet 2022: analysis of nationwide population-based data with a special focus on hypertension in the elderly
por: Kim, Hyeon Chang, et al.
Publicado: (2023)

Correction to: Korea hypertension fact sheet 2020: analysis of nationwide population-based data
por: Kim, Hyeon Chang, et al.
Publicado: (2021)

Erratum: Correction of Author’s name in the Article “Sex-Specific Trends in the Prevalence of Hypertension and the Number of People With Hypertension: Analysis of the Korea National Health and Nutrition Examination Survey (KNHANES) 1998–2018”
por: Seo, Eunsun, et al.
Publicado: (2022)

Korea Heart Disease Fact Sheet 2020: Analysis of Nationwide Data
por: Lee, Hyeok-Hee, et al.
Publicado: (2021)

Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary
por: Jermendy, György, et al.
Publicado: (2008)

Sex Differences in Cardiovascular Effectiveness of Newer Glucose‐Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus
por: Raparelli, Valeria, et al.
Publicado: (2020)

Sodium–glucose cotransporter 2 inhibitors do not increase the risk of fractures in real‐world clinical practice in Korea: A national observational cohort study
por: Ha, Kyoung Hwa, et al.
Publicado: (2022)

Association between blood glucose level derived using the oral glucose tolerance test and glycated hemoglobin level
por: Kim, Hyoung Joo, et al.
Publicado: (2016)

Dyslipidemia Fact Sheets in Korea 2020: an Analysis of Nationwide Population-based Data
por: Cho, So Mi Jemma, et al.
Publicado: (2021)

Association between sodium glucose co-transporter 2 inhibitors and a reduced risk of heart failure in patients with type 2 diabetes mellitus: a real-world nationwide population-based cohort study
por: Kim, Young-Gun, et al.
Publicado: (2018)

Adding Saxagliptin to Metformin Extended Release (XR) or Uptitration of Metformin XR: Efficacy on Daily Glucose Measures
por: Neutel, Joel M., et al.
Publicado: (2013)

A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database study
por: Choi, In Sil, et al.
Publicado: (2018)

Cost-Effectiveness of Saxagliptin Compared With Glibenclamide as a Second-Line Therapy Added to Metformin for Type 2 Diabetes Mellitus in Ethiopia
por: Bekele, Mengistu, et al.
Publicado: (2021)

Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study
por: Chan, Cheng-Wei, et al.
Publicado: (2018)

Application of New Cholesterol Guidelines to the Korean Adult Diabetic Patients
por: Kim, Bu Kyung, et al.
Publicado: (2015)

Outcomes of Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer in One Institution
por: Lee, Seok Jeong, et al.
Publicado: (2014)

Metformin acts as a dual glucose regulator in mouse brain
por: Jin, Bo-Yeong, et al.
Publicado: (2023)

Comparative Cardiovascular Risks of Dipeptidyl Peptidase-4 Inhibitors: Analyses of Real-world Data in Korea
por: Ha, Kyoung Hwa, et al.
Publicado: (2018)

Ultra-Processed Food Consumption and Obesity in Korean Adults
por: Shim, Jee-Seon, et al.
Publicado: (2023)

Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport
por: Horakova, Olga, et al.
Publicado: (2019)

Spousal concordance of ideal cardiovascular health metrics: findings from the 2014–2019 Korea National Health and Nutrition Examination Survey
por: Hoang, Manh Thang, et al.
Publicado: (2022)

Synergistic effect of metformin on sorafenib in in vitro study using hepatocellular carcinoma cell lines
por: Chung, Yong-Gyu, et al.
Publicado: (2018)

Metformin ameliorates bile duct ligation-induced acute hepatic injury via regulation of ER stress
por: Lee, Chi-Ho, et al.
Publicado: (2020)

Modified MVAC as a Second-Line Treatment for Patients with Metastatic Urothelial Carcinoma after Failure of Gemcitabine and Cisplatin Treatment
por: Lee, Jung Hyun, et al.
Publicado: (2014)

Trends in the Incidence, Prevalence, and Mortality of End-Stage Kidney Disease in South Korea
por: Lee, Min-Jeong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ntgke9dj1t35leautuoq3m6g12